NASDAQ: LQDALiquidia Corp Stock Ownership - Who owns Liquidia?
Insider buying vs selling
Have Liquidia Corp insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Scott Moomaw | Chief Commercial Officer | 2025-12-01 | 831 | $32.19 | $26.75kSell |
| Dana Boyle | Chief Accounting Officer | 2025-12-01 | 303 | $32.19 | $9.75kSell |
| Michael Kaseta | CFO and COO | 2025-12-01 | 1,166 | $32.19 | $37.53kSell |
| Jason Adair | Chief Business Officer | 2025-12-01 | 693 | $32.19 | $22.31kSell |
| Russell Schundler | General Counsel | 2025-12-01 | 1,072 | $32.19 | $34.51kSell |
| Sarah Krepp | Chief Human Resource Officer | 2025-12-01 | 221 | $32.19 | $7.11kSell |
| Jason Adair | Chief Business Officer | 2025-11-18 | 35,291 | $5.89 | $207.86kBuy |
| Jason Adair | Chief Business Officer | 2025-11-18 | 365 | $5.89 | $2.15kBuy |
| Jason Adair | Chief Business Officer | 2025-11-18 | 35,656 | $30.03 | $1.07MSell |
| Dana Boyle | Chief Accounting Officer | 2025-11-07 | 8,342 | $25.16 | $209.88kSell |
LQDA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when LQDA insiders and whales buy or sell their stock.
LQDA Shareholders
What type of owners hold Liquidia Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Caligan Partners LP | 18.93% | 16,467,369 | $566.64M | Insider |
| Farallon Capital Management LLC | 9.85% | 8,565,638 | $294.74M | Institution |
| David Edward Johnson | 9.38% | 8,157,347 | $280.69M | Insider |
| Caligan Partners LP | 9.33% | 8,118,892 | $279.37M | Institution |
| Blackrock Inc | 6.01% | 5,228,806 | $179.92M | Institution |
| Paul B. Manning | 4.63% | 4,030,129 | $138.68M | Insider |
| Vanguard Group Inc | 4.55% | 3,961,217 | $136.31M | Institution |
| Stephen M. Bloch | 3.40% | 2,955,924 | $101.71M | Insider |
| Canaan VIII LP | 3.35% | 2,917,169 | $100.38M | Insider |
| Findell Capital Management LLC | 3.25% | 2,830,000 | $97.38M | Institution |
LQDA vs Biotech Stocks
Liquidia Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.